Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

95.78 +0.74 (+0.78%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
Why Medtronic Stock Marched Higher on Monday
Via The Motley Fool
Pain Neuromodulation Market to Reach $6.5 Billion by 2030
SAN FRANCISCO, Calif., March 31, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the newsletter Neurotech Business Report, announced the availability of a new market research report... 
Via Send2Press
Prediction: Buying Medtronic Today Will Set You Up for Life
Via The Motley Fool
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
Analyst Expectations For Medtronic's Future
 
Via Benzinga
Medtronic Stock Gets IBD Rating Lift
In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier. 
Via Investor's Business Daily
Is Medtronic Stock a Buy?
The medical device maker has been a huge winner for its long-term shareholders. 
Via The Motley Fool
2 Recession-Proof Dividend Stocks to Buy and Hold
Via The Motley Fool
Spring Into Action – Don't Let Varicose Veins Hold You Back
(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of... 
Via NewsUSA
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid... 
Via Benzinga
Topics World Trade
Spring Forward – Don’t Let Varicose Veins Hold You Back
(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of... 
Via NewsUSA
Why Medtronic Stock Is Sinking Today
Via The Motley Fool
Why MEDTRONIC PLC (NYSE:MDT) provides a good dividend, while having solid fundamentals.
Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT). 
Via Chartmill
5 Dividend Stocks That Motley Fool Experts Are Watching Right Now
Via The Motley Fool
Biogen VP to Keynote 2025 Bioelectronic Medicine Forum in NYC
NEW YORK, N.Y., March 17, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth Annual... 
Via Send2Press
Kroger CEO Shake-Up
Via The Motley Fool
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
From FN Media Group LLC
Via GlobeNewswire
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:ACON),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
2 Dependable Dividend Stocks That Can Pay You for Life
Via The Motley Fool
This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
MEDTRONIC PLC (NYSE:MDT) is setting up nicely for a breakout.
MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know. 
Via Chartmill
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency. 
Via Benzinga
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
Via The Motley Fool
MarketBeat Week in Review – 02/17 - 02/21
Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news 
Via MarketBeat
Topics Economy
Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off. 
Via MarketBeat
The Smartest Dividend Stocks to Buy With $1,000 Right Now
Via The Motley Fool
Medtronic Logs Worst Day In Nearly 5 Years On Q3 Revenue Miss, But Retail Goes Bargain Hunting
The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns. 
Via Stocktwits
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday.
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.